Inhalation Therapy of Calcitonin Relieves Osteoarthritis of the Knee


ARMAĞAN O. , Serin D. K. , ÇALIŞIR C. , Dokumacioglu A., ÖZGEN M. , Oner S. , ...More

JOURNAL OF KOREAN MEDICAL SCIENCE, vol.27, no.11, pp.1405-1410, 2012 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 11
  • Publication Date: 2012
  • Doi Number: 10.3346/jkms.2012.27.11.1405
  • Title of Journal : JOURNAL OF KOREAN MEDICAL SCIENCE
  • Page Numbers: pp.1405-1410
  • Keywords: Nasal Salmon Calcitonin, Knee Osteoarthritis, Exercise, SALMON-CALCITONIN, ARTICULAR CHONDROCYTES, RADIOGRAPHIC SUBTYPES, EXERCISE THERAPY, II DEGRADATION, MULTIPLE SITES, CARTILAGE, URINARY, BONE, PATHOPHYSIOLOGY

Abstract

This study was conducted to determine if nasal salmon calcitonin has additional beneficial effects on clinical symptoms, serum NO, IL-1 beta, matrix metalloproteinase 3, urinary C-terminal telopeptide type II collagen (CTX-II) levels and MRI findings in knee osteoarthritis (OA) when used concomitantly with exercise therapy. Fifty female patients with knee OA were randomized into two groups. The first group (n = 30) received 200 IU/day nasal salmon calcitonin and a home exercise program; the second group (n = 20) received a home exercise program for 6 months. Compared with baseline, while significant improvements were observed in visual analogue scale (VAS), WOMAC pain, physical function scores, 20-m walking time (P<0.001) and WOMAC stiffness score (P=0.041) in the first group, walking and resting VAS, and WOMAC physical function scores were improved (P=0.029) in the second group after treatment. Significantly increased levels of serum NO and urinary CTX-II (P<0.001) and significant improvements in the area of medial femoral condyle (P<0.05) were noted only in the first group. There were significant differences in VAS activation values (P=0.032) and NO levels (P<0.001) in the favor of the first group. In conclusion, nasal salmon calcitonin may have possible chondroprotective effects besides its known effects on symptoms in patients with knee OA.